Ranolazine 27241-0125
Product NDC
27241-0125- Manufacturer
- Ajanta Pharma Usa Inc.
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 23, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA210054
Need to source Ranolazine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ranolazine | 500 mg/1 |
Drug Class
Anti-anginal [EPC]Anti-anginal [EPC]Cytochrome P450 2D6 Inhibitors [MoA]
Packaging Options(2)
60 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-125-02)
500 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-125-05)